Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thiran Udawatta

Foot and Ankle Surgery Bellingham, WA Medical Doctor

NPI 1073925087 CMS profile 4220461

2979 Squalicum Pkwy Ste 203, Bellingham, WA 98225

Open in the dashboard

General payments

$16,692

134 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thiran Udawatta of Bellingham, WA is reported in the CMS Open Payments database as having received $16,692 across 134 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 64th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,486 31
2024 General $499 11
2023 General $1,557 17
2022 General $5,924 60
2021 General $3,940 14
2019 General $2,286 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thiran Udawatta
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to Thiran Udawatta were reported at $2,486. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year Thiran Udawatta Foot and Ankle Surgery median Middle half National median
2019 $2,286 $1,327 $279–$5,421 $163
2020 $0 $795 $121–$3,473 $114
2021 $3,940 $1,289 $201–$4,963 $132
2022 $5,924 $1,539 $270–$6,067 $149
2023 $1,557 $1,117 $257–$5,264 $160
2024 $499 $1,064 $235–$4,944 $164
2025 $2,486 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $4,356 52 payments
  2. Arthrex, Inc. $3,265 24 payments
  3. Summit Surgical Corp. $3,079 5 payments
  4. Elite Orthopedics, LLC $2,286 1 payment
  5. Smith+Nephew, Inc. $1,816 17 payments
  6. Stryker Corporation $882 8 payments
  7. Paragon 28, Inc. $318 3 payments
  8. Orthofix Medical, Inc. $102 5 payments
  9. Integra LifeSciences Corporation $88 1 payment
  10. Bioventus LLC $84 3 payments
  11. Other $415 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $7,250 7 payments
  2. Travel and Lodging $5,330 30 payments
  3. Food and Beverage $4,023 96 payments
  4. Long term medical supply or device loan $88 1 payment
Products named General payments · program years 2019–2025
  1. Avenir $1,485 20 payments
  2. EVOS Trauma Plates, Screws, and Nails $1,079 7 payments
  3. Bone Anchors with Arthroscopic Delivery System $1,000 6 payments
  4. Oxford $699 8 payments
  5. InCore Lapidus $612 5 payments
  6. Trabecular Metal $369 6 payments
  7. EVOS Trauma Plates, Screws, and Nails $347 3 payments
  8. Panta 2 $331 4 payments
  9. HAT-TRICK $331 4 payments
  10. EVOS MINI $331 5 payments
  11. Other $2,546 46 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

203

Median for Orthopedic Surgery: 203

Drug cost

$1,266

Median for Orthopedic Surgery: $1,433

Branded share of claims

43.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Nitroglycerin Patch Nitroglycerin Brand 27 $648
Ondansetron Odt Ondansetron Brand 61 $271
Oxycodone Hcl Generic 76 $222
Pregabalin Generic 39 $126

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 87 billing codes

Paid by Medicare

$101,710

Of which drugs: $1,132

Medicare patients

287

Average age 74

Services billed

1,717

170 women, 117 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 73%
High blood pressure 67%
Ischemic heart disease 29%
Depression 25%
Chronic kidney disease 22%
Osteoporosis 21%
Atrial fibrillation 19%
Heart failure 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 19 1,000 $98

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

134 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record